Printer Friendly

Benign chondroid syringoma.


A 38-year-old woman presented with a mass on her left hand that had been gradually increasing in size over a 3-year period. Hand radiography was obtained, followed by contrast-enhanced magnetic resonance imaging (MRI).


Radiography of the hand showed no abnormalities (not shown). MRI revealed an oval 1.3-cm mass in the volar subdermal tissue immediately superficial to the flexor tendons of the second digit (Figure 1).


At the time of excision, gross pathologic analysis revealed well-encapsulated tan tissue (Figure 2). No areas of hemorrhage or necrosis were noted. Histologically, the lesion was nodular, and there was differentiation toward the adnexal ductal epithelium with chon dro myxoid and adipocytic differentiation in the stroma.


Benign chondroid syringoma (mixed tumor)


A chondroid syringoma is a rare mixed tumor of sweat-gland origin that has both a benign and malignant form. (1,2) The term chondroid syringoma was introduced by Hirsch and Helwig in 1961 because of the cartilaginous matrix (chondroid) and sweat-gland elements (syringoma). (2,3) They usually are adherent to the skin and should have no attachments to the deep structures. (3) Up to 80% of benign lesions occur on the head or neck and usually occur in adults >35 years of age. (1,3) These tumors have a reported male-to-female predilection ranging from 2:1 to 5:1.


There have been few reported cases of malignant chondroid syringoma. The majority of the reported malignant cases occur on the extremities or trunk and there is a 2:1 female-to-male predominance. The average age at diagnosis is 48. (2) Common locations of metastases include regional lymph nodes (48%), lung and bone. (2) The treatment of choice for chondroid syringoma is a wide surgical excision. (3) Incomplete removal secondary to the lobulations and satellite lesions is hypothesized to cause local recurrence. (3)

At the time of removal, the tumors are typically firm, circumscribed whitish-yellow nodules. Histologically, the tumors contain varying amounts of: nests of cuboidal/polygonal cells, tubuloalveolar structures, ductal structures, keratinous cysts and matrix (chondroid substance is the most prevalent). (2) On samples from fine-needle aspiration biopsy, there is a usually mesenchymal tissue with a chon droid appearance and an epithelial component.


It has been argued that the distinction of malignant versus benign can be made by malignant cytology features, but this is somewhat in question, as there have been 4 reported cases of metastases without malignant features. (2) Ishimura believed that the true malignant potential was better measured as a function of the amount of matrix and chondroid differentiation. (2)

No reports providing the MRI characteristics of benign chondroid syringoma were found in our search of literature, but the MRI appearance of a malignant chondroid syringoma has been described. (4) This lesion was slightly higher in signal intensity than muscle on the proton-density sequence, had heterogeneously increased signal on the T2-weighted images, and had high signal with focal regions of intermediate signal on the short T1 inversion recovery (STIR) images. This benign lesion was slightly hyperintense relative to muscle on the T1-weighted images, had heterogeneously increased signal on the T2-weighted images, and showed heterogeneous but diffuse enhancement.


Chondroid syringoma is a rare subcutaneous tumor composed of mesenchymal and sweat gland elements that is usually found in the head and neck. This tumor is most often benign and is usually seen in men. When the malignant form occurs, it is seen more commonly in women and is found on the extremities or trunk. When malignant, it can invade locally as well as metastasize to lymph nodes, lung or bone. The MRI characteristics of the lesion are nonspecific, but could aid in identifying the extent of the tumor. Excision is the treatment of choice, thereby making early identification advantageous. Importantly, the histology does not always predict the clinical behavior of the tumor, and benign-appearing lesions have been known to metastasize.


(1.) Terrill RQ, Groves RJ, Cohen MB. Two cases of chondroid syringoma of the hand. J Hand Surg [Am]. 1987;12:1094-1097.

(2.) Barnett MD, Wallack MK, Zuretti A, et al. Recurrent malignant chondroid syringoma of the foot: A case report and review of the literature. Am J Clin Oncol. 2000;23:227-232.

(3.) Chen AH, Moreano EH, Houston B, Funk GF. Chondroid syringoma of the head and neck: Clinical management and literature review. Ear Nose Throat J. 1996;75:104-108.

(4.) Nicolaou S, Dubec JJ, Munk PL, et al. Malignant chondroid syringoma of the skin: Magnetic resonance imaging features. Australas Radiol. 2001;45:240-243.

James D. Lowe, MD, Justin Q. Ly, MD, Joanna D. Lusk, MD, and Douglas P. Beall, MD

Prepared by James D. Lowe, MD, Justin Q. Ly, MD, Joanna D. Lusk, MD, and Douglas P. Beall, MD, Wilford Hall Medical Center, Lackland AFB, TX.
COPYRIGHT 2009 Anderson Publishing Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Lowe, James D.; Ly, Justin Q.; Lusk, Joanna D.; Beall, Douglas P.
Publication:Applied Radiology
Article Type:Case study
Geographic Code:1USA
Date:Apr 1, 2009
Previous Article:MRI in the era of nephrogenic systemic fibrosis: review, controversies and suggestions for risk reduction.
Next Article:Atrial septal aneurysm.

Related Articles
Diagnosis of Chondroid Lipoma by Fine-Needle Aspiration Biopsy.
Chondrosarcoma of the larynx. (Imaging Clinic).
Chondroma of the nasal bone: a case report.
Radiological case of the month: Omer Etlik, MD.
Radiological case of the month: Kush Kumar, MD, and Raghuveer K. Halkar, MD.
Radiological case of the month: Nelson G. Uzquiano, MD, and Douglas P. Beall, MD.
Hydatid cyst.
Atrial septal aneurysm.
Splenogonadal fusion.
Acute calcific prevertebral tendonitis of the longus colli muscle.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters